The Impact on Outcome by Adding Bevacizumab to Standard Induction Chemotherapy Prior to Mesothelioma Surgery: A Retrospective Single Center Analysis

Overview of attention for article published in Frontiers in oncology, November 2020

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: The Impact on Outcome by Adding Bevacizumab to Standard Induction Chemotherapy Prior to Mesothelioma Surgery: A Retrospective Single Center Analysis. https://t.co/ifI6yZztuY #colorectalcancer #oncology https://t.co/olrMECBiRx

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.